Conference Call with Torrent Pharmaceuticals Ltd. Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript.
Torrent Pharmaceuticals announced Q2FY24 results: 1. Revenues from India: In Q2FY24, Torrent Pharmaceuticals generated revenues of Rs 1,444 crore from its operations in India. This represents a growth of 18% compared to the same period last year. 2. Revenues from the United States: The company reported revenues of Rs 248 crore from its operations in the United States during Q2FY24. This reflects a decline of 15% compared to the corresponding quarter of the previous fiscal year. 3. Revenues from Germany: Torrent Pharmaceuticals generated revenues of Rs 266 crore from its operations in Germany in the Q2FY24. This indicates a growth of 21% compared to the same period last year. 4. Revenues from Brazil: The company reported revenues of Rs 252 crore from its operations in Brazil during Q2FY24.. This represents a substantial growth of 36% compared to the corresponding quarter of the previous fiscal year. 5. Revenues from Other Countries: Torrent Pharmaceuticals generated revenues of Rs 280 crore from its operations in other countries during the Q2FY24. This reflects a growth of 17% compared to the same period last year. 6. Other Revenues: The company reported revenues of Rs 170 crore from other sources during Q2FY24. 7.Overall, Torrent Pharmaceuticals reported total revenues of Rs 2,660 crore in Q2FY24, reflecting a growth of 16% compared to the same period last year. Result PDF